Home › Sustainable Materials › Papyrus Australia (ASX:PPY)

Papyrus opens commercial path for biodegradable Collar Keeper range

Sustainable Materials By Victor Sage 3 min read

Papyrus has secured acceptance for the first product in its biodegradable Collar Keeper range, opening the door to commercial supply with TBS Mining Solutions. The milestone covers 25% of the contract’s minimum volumes, but production readiness, funding and further product testing remain decisive.

  • First Biodegradable Collar Keeper product accepted after certification testing
  • Initial product represents 25% of minimum contract volumes
  • Potential value of approximately $1.05 million over three years at initial base pricing
  • Minimum purchases now depend on Adelaide production readiness
  • Further products must be accepted to unlock the full contract volume

First Collar Keeper product accepted for supply

Papyrus Australia Limited (ASX:PPY) has moved its biodegradable Collar Keeper range from testing into commercial supply, after TBS Mining Solutions accepted the first product following certification testing. TBS, a wholly owned subsidiary of Aquirian Limited (ASX:AQN), has also placed an initial order, although Papyrus said it was not material in value.

The acceptance follows the second production-scale TBS run reported in earlier coverage, which produced improved internal test results and sent samples to TBS for acceptance testing. Under Variation No. 2, Papyrus and TBS can now approve products individually rather than waiting for the full range to clear testing.

First product represents 25% of contract volumes

The accepted product accounts for 25% of the minimum purchase volumes under the supply contract. If that share remains unchanged across all three minimum-purchase years, Papyrus estimates the volumes would be worth approximately $1.05 million at the initial base board price. That is 25% of the approximately $4.2 million value previously associated with the full range, which earlier coverage described as an estimated TBS supply contract.

Papyrus is explicit that the $1.05 million figure is not forecast or guaranteed revenue. Minimum purchases only begin two months after the company issues a Production Ready Notice, actual sales depend on TBS orders and the contract continuing, and TBS is required to pay a standby fee on any shortfall against the minimum.

Adelaide facility now sets the commercial timetable

The previous 1 March 2027 start date has been replaced. Papyrus will use reasonable endeavours to commission production equipment at its Adelaide facility within six months of signing the variation, with timing dependent on funding, permits and commissioning. Until the facility is ready, TBS can place orders up to an agreed monthly volume through Papyrus’s existing supply chain, with those orders counting towards the first year’s minimum.

The commercial opportunity therefore grows in stages. Each accepted product adds its agreed share of minimum volumes, while the full minimum applies only once the entire range has been accepted. Papyrus and TBS are targeting staged launches for the rest of the range during the first half of 2027, with the next priority product representing a further 25% of contract volumes. Those are targets rather than commitments and depend on successful testing, funding and permits.

Termination rights remain tied to execution

Variation No. 2 also gives TBS a cost-free exit if Papyrus does not issue its Production Ready Notice within six months, if products representing at least 60% of minimum volumes have not been accepted within 12 months, or if key priority products cannot reasonably be developed. Pricing and Papyrus’s exclusivity arrangements remain unchanged.

For shareholders, the acceptance is a tangible commercial milestone, but not yet a revenue inflection point. The next evidence will come from the Adelaide commissioning process, the first meaningful orders and whether Papyrus can convert the remaining testing pipeline into accepted products before the revised milestones begin to bite.

Bottom Line?

The first acceptance validates part of the Collar Keeper program, but the investment case still turns on Adelaide commissioning, funding and acceptance of enough products to reach the 60% milestone.

Questions in the middle?

  • Can Papyrus commission the Adelaide production equipment within the six-month window, given its stated dependence on funding and permits?
  • Will TBS’s initial order develop into recurring commercial purchases once production is ready?
  • Can the remaining Collar Keeper products pass field-specific testing quickly enough to reach at least 60% of minimum volumes within 12 months?

Sources